Global ssAAV Virus Packaging Services Market Growth (Status and Outlook) 2025-2031

The global ssAAV Virus Packaging Services market size is predicted to grow from US$ 6261 million in 2025 to US$ 9815 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.

ssAAV virus packaging services refer to the production of single-stranded adeno-associated virus (ssAAV) vectors for applications such as gene therapy and gene editing. These services are typically offered by specialized biotechnology companies to produce high-quality ssAAV vectors for clients. ssAAV is a variant of adeno-associated virus (AAV) that uses single-stranded DNA as the vector. It has efficient gene delivery capabilities and low immunogenicity, making it widely used in gene therapy, vaccine development, and basic research.

United States market for ssAAV Virus Packaging Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for ssAAV Virus Packaging Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for ssAAV Virus Packaging Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key ssAAV Virus Packaging Services players cover Packgene, VectorBuilder, Ubigene, GenScript, Abace Biology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “ssAAV Virus Packaging Services Industry Forecast” looks at past sales and reviews total world ssAAV Virus Packaging Services sales in 2024, providing a comprehensive analysis by region and market sector of projected ssAAV Virus Packaging Services sales for 2025 through 2031. With ssAAV Virus Packaging Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ssAAV Virus Packaging Services industry.

This Insight Report provides a comprehensive analysis of the global ssAAV Virus Packaging Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ssAAV Virus Packaging Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ssAAV Virus Packaging Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ssAAV Virus Packaging Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ssAAV Virus Packaging Services.

This report presents a comprehensive overview, market shares, and growth opportunities of ssAAV Virus Packaging Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Non-purified ssAAV
Purified ssAAV

Segmentation by Application:
Gene Therapy
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Packgene
VectorBuilder
Ubigene
GenScript
Abace Biology
Genecfps
GENEWIZ
Obio Technology
Charles River Laboratories
Takara Bio
abm
Cell Biolabs
Cyagen
Vector Biolabs
Lonza
Oxford BioMedica
Catalent
Wuxi Shengji Pharmaceuticals
Boten Biotech
Cytiva

Please note: The report will take approximately 2 business days to prepare and deliver.